Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-13-001741
Filing Date
2013-08-05
Accepted
2013-08-05 16:11:00
Documents
1
Period of Report
2013-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es1300981_3-gvcllc.html 3  
1 OWNERSHIP DOCUMENT es1300981_3-gvcllc.xml 3 4970
  Complete submission text file 0000950142-13-001741.txt   6980
Mailing Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146
Business Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146 3146456600
KV PHARMACEUTICAL CO /DE/ (Issuer) CIK: 0000057055 (see all company filings)

EIN.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 2128124700
GLENVIEW CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001138995 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-09601 | Film No.: 131010377

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address
ROBBINS LAWRENCE M (Reporting) CIK: 0001228603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09601 | Film No.: 131010376